TRIM21 and Glucose intolerance: We propose a model in which the downregulated TRIM21 attenuated its suppression of PEPCK1 and FASN expression in the liver through protein degradation, which consequently leads to sustained gluconeogenesis and excessive lipid synthesis in hepatocytes, thereby greatly exacerbating insulin resistance and glucose intolerance (Fig. 8).